4Paget S. The distribution of secondary growths in cancer of the breast[J].Cancer and Metastasis Review,1889,(02):98-101.
5Kjonniksen I,Breistoi K,Fodstad O. Site-dependent differ-ences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide,but not to doxorubicin and cisplatin[J].Cancer Research,1992,(05):1374.
6Arguello F,Baggs RB,Eskenazi AE. Vascular anatomy and organ-specific tumor growth as critical factors in the develop-ment of metastasis and their distribution among organs[J].International Journal of Cancer,1991,(04):583.
7Hoffman RM. Orthotopic metastatic mouse models for anticancer drug and evaluation:a bridge to the clinic[J].Investigational New Drugs,1999,(04):343.
3[1]Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci, 1999, 19 (24) : 10886
4[2]Medhurst SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain. Pain, 2002, 96 ( 1 - 2) : 129
5[3]Walker K, Medhurst SJ, Kidd BL, et al. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain, 2002, 100 (3) :219
6[4]Fox A, Medhurst S, Courade JP, et al. Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain, 2004, 107 (1-2) :33
7[5]Kim SH, Chang JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.Pain, 1992, 50 (3) :355
8Manthyh PW,Clohisy DR,Koltzenburg M,et al.Molecular mechanisms of cancer pain.Nature Rev (Cancer) 2002;2(3):201-9
9Menendez L,Lastra A,Fresno MF,et al.Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain.Brain Res 2003;969(1-2):102-9
10Petersa CM,Ghilardid JR,Keysera CP,et al.Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.Exp Neurol 2005;193(1):85-100
